Our Products With a foundation in oral solids and the addition of liquids in 2007, the Amneal product offering continues to diversify along with our aggressive growth plan. This strategy involves proactive pursuit of tech transfers, ANDA acquisitions, site transfers and joint ventures—in addition to our own robust development pipeline—to expand our portfolio. After our most recent purchase agreement closes, Amneal will list assets of over one-hundred products approved or filed with the US FDA and in development, including controlled substances, hormonal products, high potency formulations, soft gelatin capsules, liquids, a 20+ billion unit oral solid capacity, and a venture into the ophthalmic category. The newly expanded Amneal line includes the following. • APAP/DPIM • Bethanechol Cl • Codeine/APAP • Cyclobenzaprine • Demeclocycline HCl • Docusate Sodium • EEMT • Folic Acid • Hydrocodone/APAP • Hydrocodone/Ibuprofen • Ibuprofen • Naproxen • Nicardipine HCl • Oxycodone/APAP • Primidone • SMZ/TMP • Sotalol AF • Tramadol HCl These additional products are manufactured by Amneal, through our exacting standards, and marketed by licensed partners: • Benzonatate (100/200mg) • Hydralazine (25/50mg) • Sulindac (150/200mg) • Hydrochlorothiazide (25/50mg) • Terbinafine (250mg) • Acebutelol (200/400mg) • Flecainide (50/100/150mg) • Guanfacine (1/2mg) • Hydroxizine Copyright © 2008 Amneal Pharmaceuticals. All rights reserved.